<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04494750</url>
  </required_header>
  <id_info>
    <org_study_id>EASY-PRIPCI</org_study_id>
    <nct_id>NCT04494750</nct_id>
  </id_info>
  <brief_title>Physiology and Residual Ischemia After Percutaneous Coronary Intervention</brief_title>
  <acronym>EASY-PRIPCI</acronym>
  <official_title>Physiology and Residual Ischemia After Percutaneous Coronary Intervention (EArly Discharge After Transradial Stenting of CoronarY Arteries- EASY- PRIPCI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Quebec Heart Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite optimal angiographic result after stent implantation, a number of patients will&#xD;
      undergo repeat angiography within 1 year of index procedure. EASY-PRIPCI is an observational&#xD;
      study evaluating the incidence of abnormal physiology results in patients undergoing repeat&#xD;
      angiography after uncomplicated percutaneous intervention (PCI).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite successful PCI and complete revascularization, about 25% of patients will present&#xD;
      with angina and/or positive exercise testing during follow-up. With recurring or persistent&#xD;
      symptoms, a number of those patients will be referred for control angiography. This might&#xD;
      create a significant burden for health systems as well as putting patients to undergo further&#xD;
      interventions without clear demonstration of ischemia.&#xD;
&#xD;
      Assessing physiology and fractional flow reserve in particular after PCI could represent a&#xD;
      further step to determine whether stent implantation and stenosis removal will be effective&#xD;
      to relieve subjective and objective signs of ischemia.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      Resting gradients such as whole cycle Pd/Pa and diastolic dPR and FFR will be abnormal (below&#xD;
      ischemic threshold) in &gt; 20% of cases despite optimal stent implantation and angiographic&#xD;
      result.&#xD;
&#xD;
      The use of physiology assessment in previously intervened vessels in patients referred for&#xD;
      persisting or recurring angina might help operators to decide upon further intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 18, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of successful uncomplicated PCI as per coronary physiology ratios</measure>
    <time_frame>Transprocedural, initial and final values</time_frame>
    <description>Record the minimal values reported for Pd/Pa, dPR and FFR ratios in the distal vessel after uncomplicated PCI and good angiographic result.Comparison between baseline (pre PCI) and final (post PCI) coronary physiology ratios .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence and types of further interventions or imaging techniques</measure>
    <time_frame>Historical and immediately after the procedure, up to 36 months</time_frame>
    <description>Record the incidence by type of intervention and diagnostic or imaging techniques</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual symptoms and quality of life after repeat angiography</measure>
    <time_frame>up to 30 days</time_frame>
    <description>Identify residual symptoms after intervention, and overall immediate quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of repeat interventions</measure>
    <time_frame>Historical and immediately after the procedure</time_frame>
    <description>on previously intervened lesions versus PCI on new lesions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of successful distal positioning of pressurewire</measure>
    <time_frame>Transprocedural</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <condition>Angina Pectoris</condition>
  <condition>Chest Pain</condition>
  <condition>Coronary Artery Disease</condition>
  <condition>Coronary Restenosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients returning to the Quebec Heart Institute for a diagnostic angiography and possible&#xD;
        PCI within 12 months of a previous uncomplicated PCI with stent implantation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any patient referred for diagnostic angiography and possible PCI within 12 months of&#xD;
             uncomplicated PCI with stent implantation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to understand study design or objectives of study.&#xD;
&#xD;
          -  Unable to sign informed consent.&#xD;
&#xD;
          -  Evidence of in-stent restenosis or significant untreated coronary lesions (initial&#xD;
             incomplete revascularization)&#xD;
&#xD;
          -  Inability to comply with the study follow-up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier F. Bertrand, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laval University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivier F. Bertrand, MD, PhD</last_name>
    <phone>+14186568711</phone>
    <phone_ext>5947</phone_ext>
    <email>olivier.bertrand@chul.ulaval.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>IUCPQ - Laval Hospital</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier F Bertrand, MD PhD</last_name>
      <phone>418 656 8711</phone>
      <email>olivier.bertrand@crhl.ulaval.ca</email>
    </contact>
    <investigator>
      <last_name>Olivier F Bertrand, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomas Cieza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>July 27, 2020</study_first_submitted>
  <study_first_submitted_qc>July 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2020</study_first_posted>
  <last_update_submitted>May 25, 2021</last_update_submitted>
  <last_update_submitted_qc>May 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Olivier F. Bertrand</investigator_full_name>
    <investigator_title>Director of the International Chair of Interventional Cardiology and Transradial Approach</investigator_title>
  </responsible_party>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Fractional Flow Reserve (FFR)</keyword>
  <keyword>Coronary physiology</keyword>
  <keyword>Repeat intervention</keyword>
  <keyword>diastolic pressure ratio (dPR)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Coronary Restenosis</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

